ACI 11th Annual Women Leaders in Life Sciences Law Conference

On July 25, Axinn managing partner Jeny Maier and counsel Rebecca Clegg will speak at American Conference Institute's Women Leaders in Life Sciences Law Conference, being held July 25-26 in Boston.

Jeny will speak on the "Navigating Today’s Life Sciences M&A Landscape: Charting the Latest Trends and Challenges in Pharma and Biotech Dealmaking" panel. Panelists will discuss:

• Recent growth of life sciences M&A;
• Areas of the life sciences market that are the biggest targets for investment in 2024;
• The FTC’s new “2023 Merger Guidelines” proposing new rules and reporting guidelines for mergers and if the new guidelines will impact or hinder M&A activity; 
• Latest developments and trends in antitrust enforcement in the industry and; 
• The art of life sciences business deals: strategies for success and pitfalls to look out for.

Rebecca will speak on the "Managing the Continued Fallout of the Inflation Reduction Act: Reexamining Drug Pricing, Innovation, and Commercialization Strategies in the Wake of the IRA" panel. Panelists will discuss:

• The impact that the IRA is having on investment decision, competition, and innovation;
• The elements that are being taken into account in recent ongoing price negotiations with Medicare;
• Recent lawsuits filed by drug companies to thwart federal government authority to negotiate drug prices and; 
• Practical strategies to capitalize on emerging opportunities and mitigate risks associated with pricing reforms and current market dynamics.

Click here to learn more, including how to register.